Government to assess efficacy of Evusheld against Omicron variant before buying stock

Robinson, J.

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Government to assess efficacy of Evusheld against Omicron variant before buying stock

Robinson, J..

Pharmaceutical Journal ; 308(7961), 2022.

Article in English | EMBASE | ID: covidwho-2041070

Keywords

article; comparative effectiveness; drug efficacy; government; cilgavimab plus tixagevimab

Fulltext

Print

XML

Search on Google

Full text: Available Collection: Databases of international organizations Database: EMBASE Topics: Variants Language: English Journal: Pharmaceutical Journal Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

Print

XML

Search on Google

Full text: Available Collection: Databases of international organizations Database: EMBASE Topics: Variants Language: English Journal: Pharmaceutical Journal Year: 2022 Document Type: Article